Creative Medical Technology Holdings, Inc. Class of Warrant or Right, Outstanding
Creative Medical Technology Holdings, Inc. (CELZ) had Class of Warrant or Right, Outstanding of 14.71 million shares as of 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2020-05-15
- 2020-03-31: Class of Warrant or Right, Outstanding 14.71M shares.
- 2019-12-31: Class of Warrant or Right, Outstanding 5.04M shares.
- 2019-09-30: Class of Warrant or Right, Outstanding 148.53M shares.
- 2019-06-30: Class of Warrant or Right, Outstanding 48.61M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2020-03-31 | 14.71M shares 10-Q · filed 2020-05-15 | |
| 2019-12-31 | 5.04M shares 10-Q · filed 2020-05-15 | |
| 2019-09-30 | 148.53M shares 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 48.61M shares 10-Q · filed 2019-08-13 | |
| 2019-03-31 | 58.61M shares 10-Q · filed 2019-05-20 | |
| 2018-12-31 | 142.08M shares 10-Q · filed 2019-11-14 | |
| 2018-09-30 | 255.77M shares 10-Q · filed 2018-11-14 | |
| 2018-06-30 | 77.57M shares 10-Q · filed 2018-08-14 | |
| 2018-03-31 | 95.49M shares 10-Q · filed 2018-08-03 | |
| 2017-12-31 | 23.43M shares 10-Q · filed 2018-11-14 | 22.43M shares 10-Q · filed 2018-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |